Karki, Keshav <br/><br/>
Nuclear receptor 4A2 (NR4A2) is a druggable target for glioblastomas.  [electronic resource] 

 -  Journal of neuro-oncology  Jan 2020 
 - 25-39 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1573-7373 
<br/><br/><label>Standard No.: </label>10.1007/s11060-019-03349-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis<br/>Biomarkers, Tumor--genetics<br/>Cell Movement<br/>Cell Proliferation<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Glioblastoma--drug therapy<br/>Humans<br/>Indoles--pharmacology<br/>Mice<br/>Mice, Nude<br/>Nuclear Receptor Subfamily 4, Group A, Member 2--antagonists & inhibitors<br/>Prognosis<br/>RNA, Small Interfering--genetics<br/>Survival Rate<br/>Tumor Cells, Cultured<br/>Xenograft Model Antitumor Assays